Weitz Investment Management a vendu 175 actions de Laboratory Co. of America, ce qui a contrebalancé les estimations de gains. Weitz Investment Management sold 175 shares of Laboratory Co. of America, which beat earnings estimates.

Weitz Investment Management Inc. a réduit ses participations dans Laboratory Co. of America Holdings (LH) en vendant 175 actions, qui possèdent maintenant 236 175 actions. Weitz Investment Management Inc. reduced its holdings in Laboratory Co. of America Holdings (LH) by selling 175 shares, now owning 236,175 shares. LH a déclaré un bénéfice de 3,45 $ par action, dépassant les estimations. LH reported earnings of $3.45 per share, exceeding estimates. La société a un plafond de marché de 19,47 milliards de dollars et un ratio P/E de 26,38. The company has a market cap of $19.47 billion and a P/E ratio of 26.38. D'autres investisseurs institutionnels comme Cinctive Capital et Brown Brothers Harriman ont également ajusté leurs participations dans LH. Other institutional investors like Cinctive Capital and Brown Brothers Harriman have also adjusted their stakes in LH.